Literature DB >> 8125977

RNA polymerase-associated protein Rap94 confers promoter specificity for initiating transcription of vaccinia virus early stage genes.

B Y Ahn1, P D Gershon, B Moss.   

Abstract

The association of a 94,000-Da viral polypeptide, called Rap94, with 30-40% of the multisubunit DNA-dependent RNA polymerase molecules purified from infectious vaccinia virus particles was established by immunoaffinity chromatography. The submolar amount of Rap94, relative to RNA polymerase, was confirmed by quantitative immunoblotting of total virion extracts. Only the RNA polymerase molecules containing Rap94 could functionally interact with VETF, the vaccinia virus early transcription factor, to transcribe a double-stranded DNA template regulated by a viral early stage promoter. Rap94 was required for the synthesis of short oligoribonucleotides and for the formation of stable ternary transcription complexes. With a nonspecific single-stranded DNA template, however, the Rap94-deficient polymerase had greater catalytic activity than the Rap94-containing polymerase. These data support a model in which Rap94 confers specificity to the RNA polymerase for promoters of early stage genes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8125977

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Reverse genetics analysis of poxvirus intermediate transcription factors.

Authors:  Robin D Warren; Catherine A Cotter; Bernard Moss
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

2.  Role of forward translocation in nucleoside triphosphate phosphohydrolase I (NPH I)-mediated transcription termination of vaccinia virus early genes.

Authors:  Jessica Tate; Paul Gollnick
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

3.  Genome-wide analysis of the 5' and 3' ends of vaccinia virus early mRNAs delineates regulatory sequences of annotated and anomalous transcripts.

Authors:  Zhilong Yang; Daniel P Bruno; Craig A Martens; Stephen F Porcella; Bernard Moss
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

4.  Transcription of a vaccinia virus late promoter template: requirement for the product of the A2L intermediate-stage gene.

Authors:  A L Passarelli; G R Kovacs; B Moss
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

5.  Vaccinia virus A21 virion membrane protein is required for cell entry and fusion.

Authors:  Alan C Townsley; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 6.  Multisubunit DNA-Dependent RNA Polymerases from Vaccinia Virus and Other Nucleocytoplasmic Large-DNA Viruses: Impressions from the Age of Structure.

Authors:  Yeva Mirzakhanyan; Paul D Gershon
Journal:  Microbiol Mol Biol Rev       Date:  2017-07-12       Impact factor: 11.056

Review 7.  Orthopoxvirus targets for the development of antiviral therapies.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Curr Drug Targets Infect Disord       Date:  2005-03

8.  Vaccinia virus early gene transcription termination factors VTF and Rap94 interact with the U9 termination motif in the nascent RNA in a transcription ternary complex.

Authors:  Linda A Christen; Sarah Piacente; Mohamed R Mohamed; Edward G Niles
Journal:  Virology       Date:  2008-05-01       Impact factor: 3.616

9.  Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkeypoxvirus.

Authors:  Jason Farlow; Mohamed Ait Ichou; John Huggins; Sofi Ibrahim
Journal:  Virol J       Date:  2010-05-28       Impact factor: 4.099

10.  Nucleoside Triphosphate Phosphohydrolase I (NPH I) Functions as a 5' to 3' Translocase in Transcription Termination of Vaccinia Early Genes.

Authors:  Ryan Hindman; Paul Gollnick
Journal:  J Biol Chem       Date:  2016-05-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.